|
| 
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
 |
Taiwan boosts start-ups
 |
|
| Over the last few months, Taiwan has implemented some strategic initiatives and is pumping investments into start-up biotech companies with the aim to become a competitive biotech hub
|
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Taiwan scientist receives SEBM Distinguished Scientist Award
|
|
| Dr. Nan-Shan Chang, Professor and Chair of the Institute of Molecular Medicine at National Cheng Kung University is one of the 9 recipients of the 2011 Distinguished Scientist Award by the US-based Society for Experimental Biology and Medicine (SEBM) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
|
|
Pharma Innovate Asia Taiwan on Oct 15
|
|
| Pharma Innovate Asia Taiwan 2010 is primed to be Asia's leading event for the Biopharmaceutical industry focused on the latest innovations in processes, methods, marketing and business thinking in the 21st century |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
Taiwan researchers find possible markers of stem cell
|
|
| A research team led by Dr. John Yu from Institute of Cellular and Organismic Biology, Taiwan has discovered that glycosphingolipids on the surface of cells change composition when human embryonic stem cells differentiate into specialized cells. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Pharmigene gets patents for gene detection
|
|
| Pharmigene, a leader in advancing personalized medicine and reducing severe adverse reactions to drugs through genetic-based diagnostic solutions, has been granted patents in the United States, Europe, Australia, Singapore and Taiwan |
|
|
|
|
|
Taiwan approves PharmiGene's DNA detection kit
|
|
| PharmiGene, a pharmacogenetic-based molecular diagnostic company, has received approval from the Department of Health (DOH) in Taiwan to begin marketing the PG 1502 DNA detection kit, one in the line of the company's rapid genetic tests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
GSK, Impax in $11.5 mn deal for Parkinson's drug
|
|
| GlaxoSmithKline and Impax Pharmaceuticals have announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product for the treatment of Parkinson's disease |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
Diabetes drives diagnostics market in Taiwan
|
|
| The increased incidence of diabetes in Taiwan is driving the growth of self-monitoring of blood glucose (SMBG) devices and strips market in Taiwan. Increasing awareness about the disease has been the recent focus by the Taiwanese government. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
